CTRI/2024/07/071645尚未招募4 期
An open-label, prospective, randomized controlled, single-centre pilot study evaluating the acceptability, feasibility and exploratory efficacy of transcendental meditation intervention for healthcare professionals in a tertiary care hospital in rural Jndia. - NI
SMSIMSR, Sri Sathya Sai University for Human Excellence0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Fulltime healthcare providers, medical doctors or nurses involved in active patient care or direct hospital administration.
- •2. 18 years or older
- •3. Willing to complete both baseline and post-testing
- •4. In the active treatment group, willing to dedicate the time required to learn the TM technique and practicing it twice daily for 20 minutes each time
排除标准
- •1. Already instructed in the TM technique
- •2. Currently unstable psychiatric symptoms as demonstrated by self-report, medical chart, or psychiatric hospitalizations in the past six months
- •3. Use of antipsychotic or ß blocker medications
- •4. current suicidal ideation
研究者
相似试验
尚未招募
4 期
To compare and evaluate clinical outcome of three different ophthalmic viscoelastic devices during ophthalmic surgeryCTRI/2020/02/023391Biotech Vision Care Pvt Ltd
尚未招募
不适用
Comparison of the effect of three different ophthalmic viscosurgical devices used in eye surgeryCTRI/2022/02/040026The Eye Foundation
尚未招募
3 期
A randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactionsA randomized, prospective, open-label, controlled trial comparing the efficacy of omitting H2 antagonists versus famotidine in premedication protocol for prophylaxis of taxane hypersensitivity reactionsTCTR20220913005/A140
招募中
3 期
A prospective, randomised, controlled, open-label, multicentre phase III study to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).Neuroendocrine tumor - NET10017991NL-OMON52990ITM Solucin GmbH20
进行中（未招募）
不适用
An open-label, controlled, randomized, prospective, between groups, multicenter clinical trial on the efficacy and safety of Fitostimoline (vaginal cream, vaginal suppositories and vaginal solution) and of Tantum Rosa (vaginal cream and vaginal solution) in the treatment of the vaginosis (non specific vaginitis) - NDEUCTR2008-005007-26-ITFARMACEUTICI DAMOR